Reinsurance Group of America Inc

Reinsurance Group of America Inc (RZC) Stock Analysis

$25.520

-0.031 (-0.12%)At close

Loading chart…
High
25.690
Open
25.410
VWAP
25.53
Volume
23.90K
Mkt Cap
—
Low
25.380
Amount
610.12K
EV/EBITDA, TTM
—

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The Company has four segments. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.

www.rgare.com

AI analysis of Reinsurance Group of America Inc (RZC)

Hold

Currently, RZC is not a strong buy due to its RSI of 67.319, indicating it is approaching overbought territory, and a 1-year change of -0.74%, which suggests it has underperformed over the past year. The stock is trading at $25.55, close to its 52-week high of $25.88, which limits upside potential.

RZC FAQ — answered by Alphio AI

Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The Company has four segments. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements. It operates in the Financials sector.

Currently, RZC is not a strong buy due to its RSI of 67.319, indicating it is approaching overbought territory, and a 1-year change of -0.74%, which suggests it has underperformed over the past year. The stock is trading at $25.55, close to its 52-week high of $25.88, which limits upside potential.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading